Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma

BACKGROUND: The advent of molecular medicine may allow for individualized cancer prognostication, which should enable better clinical management and, hopefully, improve patient outcomes. A 31-gene expression profile (31-GEP) test is currently available for patients diagnosed with cutaneous melanoma;...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubin, Danielle P., Dinehart, Scott M., Farberg, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Evidence-Based Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872504/
https://www.ncbi.nlm.nih.gov/pubmed/31359351
http://dx.doi.org/10.1007/s40257-019-00464-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872504/
https://www.ncbi.nlm.nih.gov/pubmed/31359351
http://dx.doi.org/10.1007/s40257-019-00464-4

Ejemplares similares